Survey Shows 76% of Poles Believe Medical Cannabis Is Effective
Looking more specifically at the CMK survey, 73% of respondents aged 19-29 and 85% of those aged 60+ agree with the statement that medicinal cannabis is an agent with proven medical efficacy. In Poland alone, up to 27% of the population, or about 10 million people, struggle with so-called chronic pain. Pain management societies around the world recommend the use of cannabis because of its clinically proven effectiveness in the course of chronic pain treatment.
A recent survey conducted by the Center for Cannabis Medicine indicates that 76 percent of Poles believe that medical cannabis is a reliable, proven, and effective medical treatment. The majority of Poles believe in the medicinal effects of cannabis and would undergo medical cannabis therapy themselves if necessary.
If you want to find more details about the latest survey on cannabis conducted by CMK in Poland and to read the latest cannabis news in the world, download for free the Hemp.im mobile app.
The survey also found that 61 percent of Poles said they would be willing to receive cannabis therapy if recommended by a doctor
Although medical cannabis has been legal in Poland for several years and is associated by those who took part in the survey with an effective drug, Poles have very little exposure to this therapy. 84% of those surveyed said their doctor had never suggested medical cannabis therapy to them or their family members.
On the positive side, more than 60% of respondents said they would use such therapy if recommended by a doctor, confirmed Grzegorz Ciężadło, board member of the Center for Cannabis Medicine
Both young and old people in Poland are in favor of hemp
Looking more specifically at the CMK survey, 73% of respondents aged 19-29 and 85% of those aged 60+ agree with the statement that medicinal cannabis is an agent with proven medical efficacy. In Poland alone, up to 27% of the population, or about 10 million people, struggle with so-called chronic pain.
Pain management societies around the world recommend the use of cannabis because of its clinically proven effectiveness in the course of chronic pain treatment. Medical cannabis is helpful in dealing with more than a thousand health problems in fields such as rheumatology, oncology, psychiatry, neurology, gynecology, urology and dermatology, among others,” noted Magdalena Nita, MD, medical director of the Center for Cannabis Medicine.
In addition, the CMK’s research indicates that activities concerning broad education about the possibilities of the cannabis plant in Poland are not being conducted at an adequate level. 21% of respondents answered definitely no to this question, and 30% rather not.
(Featured image by Tumisu via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in CANNABIS NEWS, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Bitcoin Surges 4% after US Debt Limit Suspension Deal
While the tentative agreement has yet to be approved by Congress, its announcement has already had a positive impact. BTC...
Petro Government Asks Congress to Legalize Cannabis for Adult Use in Colombia
A project that seeks to legalize the cannabis market has never gone this far before, and those who support it...
How the Fintech Sector Helps with Financial Inclusion
The fintech industry can provide financial products and services that incentivize their use through internet and smartphone access. Fintech companies...
Peridot Solar Takes Over a 135 MW Agrivoltaic Project in Sicily from Iqony Solar Energy Solutions Italia
Peridot Solar, a company in FitzWalter Capital's portfolio, which invests in a wide range of sectors and asset classes, including...
Netpharmalab Reaches €3 Million in 2022 and Anticipates a 16% Increase in 2023
The company, which has 37 people on its staff, generates 80% of its turnover in the Spanish market and the remaining...
Crypto6 days ago
IOTA Reports Progress Toward Decentralization
Featured2 weeks ago
Windcatching Plans to Install Wind Turbines on the Sea as Tall as the Eiffel Tower
Biotech4 days ago
Miwendo Opens Round of €4 Million after Capturing €1.6 Million from Health
Crowdfunding2 weeks ago
UniCredit Bank Austria Launches Ninth Crowdfunding Initiative